Machine Learning-Assisted Drug Repurposing Framework for Discovery of Aurora Kinase B Inhibitors
<b>Background:</b> Aurora kinase B (AurB) is a pivotal regulator of mitosis, making it a compelling target for cancer therapy. Despite significant advances in protein kinase inhibitor development, there are currently no AurB inhibitors readily available for therapeutic use. <b>Meth...
Saved in:
Main Authors: | George Nicolae Daniel Ion, George Mihai Nitulescu, Dragos Paul Mihai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/1/13 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proteomic profiling identifies upregulation of aurora kinases causing resistance to taxane-type chemotherapy in triple negative breast cancer
by: Bohan Ning, et al.
Published: (2025-01-01) -
Exploring Fragment Adding Strategies to Enhance Molecule Pretraining in AI-Driven Drug Discovery
by: Zhaoxu Meng, et al.
Published: (2024-09-01) -
Aurora kinase as a putative target to tick control
by: Bruno Moraes, et al.
Published: (2024-08-01) -
FingerDTA: A Fingerprint-Embedding Framework for Drug-Target Binding Affinity Prediction
by: Xuekai Zhu, et al.
Published: (2023-03-01) -
Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders
by: Muhammad Waleed Iqbal, et al.
Published: (2025-01-01)